124 related articles for article (PubMed ID: 8109211)
1. An 18-month vitreous fluorophotometric follow-up study in juvenile diabetics.
Benitez del Castillo JM; Castillo A; Garcia Sanchez J; Ruibal JL; Reverte F; Ibarra JM
Acta Ophthalmol (Copenh); 1993 Oct; 71(5):651-6. PubMed ID: 8109211
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.
Castillo A; Benitez del Castillo JM; Diaz D; Sayagues O; Ruibal JL; Garcia-Sanchez J
Graefes Arch Clin Exp Ophthalmol; 1996 Apr; 234(4):246-50. PubMed ID: 8964530
[TBL] [Abstract][Full Text] [Related]
3. Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.
Benitez del Castillo JM; Castillo A; Fernandez PC; Garcia Sanchez J
Doc Ophthalmol; 1993; 84(2):127-33. PubMed ID: 8299503
[TBL] [Abstract][Full Text] [Related]
4. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
[TBL] [Abstract][Full Text] [Related]
5. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
Schalnus R; Ohrloff C
Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
[TBL] [Abstract][Full Text] [Related]
6. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels.
Kernell A; Ludvigsson J; Finnström K
Acta Ophthalmol (Copenh); 1990 Aug; 68(4):415-20. PubMed ID: 2220357
[TBL] [Abstract][Full Text] [Related]
7. Vitreous fluorophotometry in juvenile diabetes.
Kernell A; Larsson Y; Ludvigsson J; Tenland T
Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
[TBL] [Abstract][Full Text] [Related]
8. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
Knudsen LL; Olsen T; Nielsen-Kudsk F
Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
[TBL] [Abstract][Full Text] [Related]
9. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.
White NH; Waltman SR; Krupin T; Santiago JV
Diabetes; 1982 Jan; 31(1):80-5. PubMed ID: 6759217
[TBL] [Abstract][Full Text] [Related]
10. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
Bordat B; Guirgis IR; Manderscheid JC
J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
[TBL] [Abstract][Full Text] [Related]
11. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
Retina; 1987; 7(3):170-6. PubMed ID: 3423432
[TBL] [Abstract][Full Text] [Related]
12. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
Krupin T; Waltman SR
Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
[TBL] [Abstract][Full Text] [Related]
13. [Early diagnosis of diabetic retinopathy in patients with diabetes type I, using vitreous fluorophotometry].
Janiec S; Sośnierz-Jupowiecka A; Rzendkowski M
Klin Oczna; 1994; 96(8-9):265-7. PubMed ID: 7897991
[TBL] [Abstract][Full Text] [Related]
14. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
Waltman SR
Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
[TBL] [Abstract][Full Text] [Related]
15. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
16. Vitreous fluorophotometry in juvenile-onset diabetes mellitus.
Krupin T; Waltman SR; Oestrich C; Santiago J; Ratzan S; Kilo C; Becker B
Arch Ophthalmol; 1978 May; 96(5):812-4. PubMed ID: 655917
[TBL] [Abstract][Full Text] [Related]
17. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of growth hormone in insulin-dependent diabetics after oral administration of pirenzepine. Fluorophotometric study of the vitreous body].
Benitez del Castillo JM; Ruibal JL; Reverte F; Seara G; Fernandez PC; Duran S; Casado E; Garcia Sanchez J
J Fr Ophtalmol; 1994; 17(2):110-4. PubMed ID: 8176181
[TBL] [Abstract][Full Text] [Related]
19. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control.
Sander B; Larsen M; Engler C; Lund-Andersen H; Parving HH
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):553-9. PubMed ID: 7887152
[TBL] [Abstract][Full Text] [Related]
20. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
Yoshida A; Kojima M; Ogasawara H; Ishiko S
Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
